Neutrophil elastase inhibitor reduces hepatic metastases induced by ischaemia-reperfusion in rats
Neutrophil elastase inhibitor reduces hepatic metastases induced by ischaemia-reperfusion in rats
复制标题
DOI:
10.1080/110241502321116541
复制
发表时间:
2002-01-01
期刊:
影响因子:
--
通讯作者:
Tanaka, K
中科院分区:
文献类型:
--
作者:
Doi, K;Horiuchi, T;Tanaka, K
Objective: To investigate the possibility in rats that ONO-5046 Na, a new recombinant inhibitor of neutrophil elastase, can reduce hepatic metastases induced by ischaemia-reperfusion.Design: Laboratory experimental study.Setting: Research laboratory, Japan.Subjects: Male Fischer rats.Interventions: Rats underwent 60 min of 70% partial hepatic ischaemia, after which rat colon adenocarcinoma cells (RCN-H4) were injected into the spleen. The animals were divided into two test groups and a control group. One group was given ONO-5046 Na intravenously at 10 mg/kg/hour. A second group was given a saline solution for the same period, while the controls were not made ischaemic.Main outcome measures: Three weeks after inoculation, the number of tumour nodules on the liver surface was counted. The anti-cancer effect of ONO-5046 Na was measured by monotetrazolium assay.Results: Hepatic ischaemia-reperfusion increased the number of liver metastases of RCN-H4 in both clamped and unclamped hepatic lobes. ONO-5046 Na significantly inhibited this in unclamped lobes, but had no anti-cancer effect.Conclusion: Neutrophil elastase may have an important role in increasing haematogenous liver metastases by ischaemia-reperfusion, particularly in unclamped lobes.